Ambarish Pandey MD

Cardiology•Dallas, TX

Resident

Join to View Full Profile

5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-5505
Fax+1 214-645-4915

Education & Training

University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 2014 - 2018
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2014 - 2016
University of Texas Southwestern Medical CenterMSCS, Clinical Sciences, 2014 - 2016
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2011 - 2014
Brigham and Women's HospitalPost-Doctoral Fellowship, 2010 - 2011
All India Institute of Medical SciencesClass of 2009

Certifications & Licensure

TX State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Electronic Alerts for Heart Failure Prevention in Diabetes Start of enrollment: 2021 Mar 25
Completed
Not Applicable
Roles: Principal Investigator
Polypill Strategy for Heart Failure With Reduced Ejection Fraction Start of enrollment: 2021 Nov 15
RECRUITING
EARLY_PHASE1
Roles: Contact, Principal Investigator
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Start of enrollment: 2019 Sep 20
Active, not recruiting
Phase 3
Roles: Contact
MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population Start of enrollment: 2022 Jun 01
Active, not recruiting
Not Applicable
Roles: Contact
Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2021 Nov 20
Completed
Not Applicable
Roles: Contact, Principal Investigator
Furoscix in Heart Failure Patients With Diuretic Resistance Start of enrollment: 2023 Jun 02
COMPLETED
PHASE2
Roles: Principal Investigator
Polypill in Acute Coronary Syndrome Start of enrollment: 2022 Nov 30
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Financial Support in an Underserved and Low-Income Population With Heart Failure Start of enrollment: 2023 Jun 09
RECRUITING
NA
Roles: Principal Investigator
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation Start of enrollment: 2024 Apr 24
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Polypill for Prevention of Cardiomyopathy Start of enrollment: 2024 Mar 11
RECRUITING
PHASE1, PHASE2
Roles: Principal Investigator
Food Supplementation Delivered Conditionally vs Not Among Patients With Heart Failure Start of enrollment: 2024 Apr 15
RECRUITING
NA
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

A multicenter pragmatic implementation study of AI-ECG-based clinical decision support software to identify low LVEF: Clinical trial design and methods.
Francisco Lopez-Jimenez, Heather M Alger, Zachi I Attia, Barbara Barry, Ranee Chatterjee
American Heart Journal Plus. 2025-06-01
1 citations
Adequacy of Loop Diuretic Dosing in Treatment of Acute Heart Failure: Insights from the BAN-ADHF Diuretic Resistance Risk Score.
Joseph Mauch, Max Puthenpura, Pieter Martens, Timothy Engelman, Justin L Grodin
The American Journal of Cardiology. 2025-06-01
Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure.
Bhavik Bansal, Fanny Lajeunesse-Trempe, Neil Keshvani, Carl J Lavie, Ambarish Pandey
The Canadian Journal of Cardiology. 2025-04-19

Press Mentions

$1 Million Granted to Investigate Cardiovascular Benefits of GLP-1 TherapyApril 29th, 2025
$1M Awarded to Research Link Between Cardiovascular Risk Reduction, GLP-1 UseApril 29th, 2025
Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA CardiologyMarch 12th, 2025
Join now to see all